Literature DB >> 15013426

The Vif protein of human immunodeficiency virus type 1 is posttranslationally modified by ubiquitin.

Sylvie Dussart1, Marianne Courcoul, Gilles Bessou, Marc Douaisi, Yohann Duverger, Robert Vigne, Etienne Decroly.   

Abstract

The viral infectivity factor (Vif), one of the six HIV-1 auxiliary genes, is absolutely necessary for productive infection in primary CD4-positive T lymphocytes and macrophages. Vif overcomes the antiviral function of the host factor APOBEC3G. To better understand this mechanism, it is of interest to characterize cellular proteins that interact with Vif and may regulate its function. Here, we show that Vif binds to hNedd4 and AIP4, two HECT E3 ubiquitin ligases. WW domains present in those HECT enzymes contribute to the binding of Vif. Moreover, the region of Vif, which includes amino acids 20-128 and interacts with the hNedd4 WW domains, does not contain proline-rich stretches. Lastly, we show that Vif undergoes post-translational modifications by addition of ubiquitin both in cells overexpressing Vif and in cells expressing HIV-1 provirus. Vif is mainly mono-ubiquitinated, a modification known to address the Gag precursor to the virus budding site.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15013426     DOI: 10.1016/j.bbrc.2004.01.023

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15.

Authors:  Atsushi Okumura; Gengshi Lu; Ian Pitha-Rowe; Paula M Pitha
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-24       Impact factor: 11.205

Review 2.  Role of the single deaminase domain APOBEC3A in virus restriction, retrotransposition, DNA damage and cancer.

Authors:  Yaqiong Wang; Kimberly Schmitt; Kejun Guo; Mario L Santiago; Edward B Stephens
Journal:  J Gen Virol       Date:  2015-10-20       Impact factor: 3.891

3.  Analysis of the N-terminal positively charged residues of the simian immunodeficiency virus Vif reveals a critical amino acid required for the antagonism of rhesus APOBEC3D, G, and H.

Authors:  Kimberly Schmitt; Miki Katuwal; Yaqiong Wang; Cicy Li; Edward B Stephens
Journal:  Virology       Date:  2013-12-05       Impact factor: 3.616

4.  Defining HIV-1 Vif residues that interact with CBFβ by site-directed mutagenesis.

Authors:  Yusuke Matsui; Keisuke Shindo; Kayoko Nagata; Katsuhiro Io; Kohei Tada; Fumie Iwai; Masayuki Kobayashi; Norimitsu Kadowaki; Reuben S Harris; Akifumi Takaori-Kondo
Journal:  Virology       Date:  2013-11-26       Impact factor: 3.616

5.  Regulation of Apobec3F and human immunodeficiency virus type 1 Vif by Vif-Cul5-ElonB/C E3 ubiquitin ligase.

Authors:  Bindong Liu; Phuong Thi Nguyen Sarkis; Kun Luo; Yunkai Yu; Xiao-Fang Yu
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

6.  Core Binding Factor β Protects HIV, Type 1 Accessory Protein Viral Infectivity Factor from MDM2-mediated Degradation.

Authors:  Yusuke Matsui; Keisuke Shindo; Kayoko Nagata; Noriyoshi Yoshinaga; Kotaro Shirakawa; Masayuki Kobayashi; Akifumi Takaori-Kondo
Journal:  J Biol Chem       Date:  2016-10-07       Impact factor: 5.157

7.  HIV-1 Vif and APOBEC3G: multiple roads to one goal.

Authors:  Joao Goncalves; Mariana Santa-Marta
Journal:  Retrovirology       Date:  2004-09-21       Impact factor: 4.602

8.  Mutations in the highly conserved SLQYLA motif of Vif in a simian-human immunodeficiency virus result in a less pathogenic virus and are associated with G-to-A mutations in the viral genome.

Authors:  Kimberly Schmitt; M Sarah Hill; Autumn Ruiz; Nathan Culley; David M Pinson; Scott W Wong; Edward B Stephens
Journal:  Virology       Date:  2008-11-21       Impact factor: 3.616

Review 9.  Ubiquitination and SUMOylation in HIV Infection: Friends and Foes.

Authors:  Marta Colomer-Lluch; Sergio Castro-Gonzalez; Ruth Serra-Moreno
Journal:  Curr Issues Mol Biol       Date:  2019-08-18       Impact factor: 2.081

10.  HIV-1 Vif: a guardian of the virus that opens up a new era in the research field of restriction factors.

Authors:  Akifumi Takaori-Kondo; Keisuke Shindo
Journal:  Front Microbiol       Date:  2013-02-20       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.